Photothermal therapies to improve immune checkpoint blockade for cancer

Photothermal therapies to improve immune checkpoint blockade for cancer

Immune checkpoint blockade (ICB) comprising monoclonal antibodies (mAbs) against immune ‘checkpoints’, such as CTLA-4 and the PD1/PDL1 axis have dramatically improved clinical outcomes for patients with cancer. However, ICB by itself has failed to provide benefit in a wide range of solid tumors, whe...

Full description

Bibliographic Details
Main Authors: Preethi B. Balakrishnan, Elizabeth E. Sweeney, Anvitha S. Ramanujam, Rohan Fernandes
Format: Article
Language:English
Published: Taylor & Francis Group 2020-12-01
Series:International Journal of Hyperthermia
Subjects:
photothermal therapy
nanoparticle
immune checkpoint blockade
immunotherapy
cancer
thermal ablation
Online Access:http://dx.doi.org/10.1080/02656736.2020.1797190

Similar Items

Similar Items